Deutsche Reaffirms Shire Plc (LON:SHP)’s “Buy” Rating; Cimpress N.V. (CMPR) Covered By 3 Bullish Analysts Last Week

April 17, 2018 - By Maria Brooks

Cimpress N.V. (NASDAQ:CMPR) Logo

Among 12 analysts covering Cimpress (NASDAQ:CMPR), 3 have Buy rating, 3 Sell and 6 Hold. Therefore 25% are positive. Cimpress had 23 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Barrington Research on Friday, December 4 with “Outperform”. The rating was maintained by SunTrust with “Hold” on Friday, October 27. As per Monday, September 18, the company rating was upgraded by Barrington Research. On Wednesday, June 1 the stock rating was downgraded by Axiom Capital to “Sell”. The firm has “Hold” rating by Cantor Fitzgerald given on Tuesday, April 26. The firm has “Neutral” rating by Suntrust Robinson given on Wednesday, December 30. The firm earned “Hold” rating on Wednesday, June 21 by Jefferies. The stock has “Market Perform” rating by Barrington Research on Wednesday, June 15. The rating was maintained by Barrington Research with “Outperform” on Tuesday, August 4. Cantor Fitzgerald upgraded it to “Buy” rating and $86 target in Friday, August 21 report. See Cimpress N.V. (NASDAQ:CMPR) latest ratings:

26/01/2018 Broker: Aegis Capital Old Rating: Hold New Rating: Sell Old Target: $85 Downgrade
14/11/2017 Broker: Barrington Rating: Buy New Target: $125.0 Maintain
27/10/2017 Broker: SunTrust Rating: Hold New Target: $100.0 Maintain

In a research report sent to investors on Tuesday morning, Shire Plc (LON:SHP) stock had its “Buy” Rating kept by research professionals at Deutsche.

Among 27 analysts covering Shire PLC (LON:SHP), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. Shire PLC has GBX 8000 highest and GBX 214 lowest target. GBX 4765.15’s average target is 31.58% above currents GBX 3621.5 stock price. Shire PLC had 438 analyst reports since July 24, 2015 according to SRatingsIntel. Deutsche Bank maintained the stock with “Buy” rating in Tuesday, January 3 report. The stock of Shire plc (LON:SHP) earned “Outperform” rating by Bernstein on Monday, December 7. Liberum Capital maintained Shire plc (LON:SHP) on Tuesday, July 12 with “Buy” rating. Liberum Capital maintained Shire plc (LON:SHP) on Wednesday, June 14 with “Hold” rating. The firm has “Outperform” rating by BNP Paribas given on Wednesday, June 15. The stock of Shire plc (LON:SHP) earned “Buy” rating by Deutsche Bank on Friday, June 30. The firm earned “Buy” rating on Friday, July 24 by Deutsche Bank. The stock of Shire plc (LON:SHP) earned “Outperform” rating by BNP Paribas on Monday, January 18. The firm has “Buy” rating by AlphaValue given on Thursday, March 10. The company was maintained on Wednesday, May 3 by Deutsche Bank.

Shire plc, a biotechnology company, focused on serving people with rare diseases and other specialized conditions worldwide. The company has market cap of 32.77 billion GBP. The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. It has a 7.74 P/E ratio. The Company’s marketed products include ADVATE and ADYNOVATE/ADYNOVI for hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand Disease; FEIBA to treat hemophilia A and B patients with inhibitors; CINRYZE and FIRAZYR for hereditary angioedema; ELAPRASE to treat hunter syndrome; REPLAGAL for Fabry disease; and VPRIV to treat type 1 Gaucher disease.

The stock increased 1.76% or GBX 62.5 during the last trading session, reaching GBX 3621.5. About 2.15 million shares traded. Shire plc (LON:SHP) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Cimpress N.V. operates as a technology based firm in North America, Europe, Australia, New Zealand, South America, the Asia Pacific, and internationally. The company has market cap of $4.78 billion. It aggregates individually customized orders for a range of print, signage, apparel, and related products primarily through the Internet. It currently has negative earnings. The firm operates through four divisions: Vistaprint, Upload and Print, National Pen, and All Other Businesses.

The stock increased 2.31% or $3.52 during the last trading session, reaching $155.71. About 59,886 shares traded. Cimpress N.V. (NASDAQ:CMPR) has risen 89.17% since April 17, 2017 and is uptrending. It has outperformed by 77.62% the S&P500.

Cimpress N.V. (NASDAQ:CMPR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: